alosetron has been researched along with Cochlear Hearing Loss in 1 studies
alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henney, JE | 1 |
1 other study available for alosetron and Cochlear Hearing Loss
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Administration, Inhalation; Adult; Anti-Inflammatory Agents; Asthma; Budesonide; Carbolines; Child; | 2000 |